Real-time Symptom Monitoring Using ePROs to Prevent Adverse Events During Care Transitions
Trial terminated
Also in this update: Phase changed: not applicable → Phase 1/2; Final enrollment: 937 participants (planned 1300)
Brigham and Women's HospitalPhase 1/2 NCT05282654 Registry history of NCT05282654 on ClinicalTrials.gov (opens the registry)